Quality Of Life With Adjuvant Gefitinib Versus Vinorelbine Plus Cisplatin In Patients With Completely Resected Stage Ii-Iiia (N1-N2) Egfr-Mutant Non-Small Cell Lung Cancer: Results From The Adjuvant (Ctong1104) Study

ANNALS OF ONCOLOGY（2020）

引用 5|浏览57

暂无评分

摘要

Adjuvant gefitinib is associated with improved HRQoL over VP, supporting its use in patients with stage II-IIIA (N1-N2), EGFR-mutant NSCLC.

查看译文

关键词

Adjuvant therapy,Chemotherapy,Gefitinib,Health-related quality of life,Non-small-cell lung cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要